Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited Metastatic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01948336
What this trial is testing

The Effects of Dexmedetomidine on Early Stage Renal Functions in Pediatric Patients

Who this might be right for
Renal Function DisorderHemodynamic Instability
TC Erciyes University 60
Not applicableLooking for participantsNCT07309211
What this trial is testing

Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT

Who this might be right for
SCLC, Limited Stage
The First Affiliated Hospital with Nanjing Medical University 25
Not applicableStudy completedNCT03946683
What this trial is testing

Cyberknife for Early Stage Breast Cancer

Who this might be right for
Early Stage Breast Cancer
NYU Langone Health 26
Testing effectiveness (Phase 2)Ended earlyNCT01138722
What this trial is testing

Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational Trial

Who this might be right for
Early Stage Non-small Cell Lung Cancer
University Hospital, Ghent 1
Not applicableNot Yet RecruitingNCT07196592
What this trial is testing

Development of a Novel Multidimensional Therapeutic Intervention Protocol for MCI

Who this might be right for
MCI-AD, Early Stage Alzheimer's Disease
Yuan Shen 300
Very early researchNot Yet RecruitingNCT07498439
What this trial is testing

TILs Therapy for Multiple Primary Early-Stage NSCLC

Who this might be right for
Primary Early-stage Non-small Cell Lung Cancer
Tianjin Medical University General Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02526498
What this trial is testing

Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor PositiveInvasive Breast Carcinoma+4 more
Rutgers, The State University of New Jersey 200
Not applicableUnknownNCT04033393
What this trial is testing

Dual-task Performance in Young-onset PD

Who this might be right for
Early Onset Parkinson DiseaseEarly Stage Parkinson Disease
National Yang Ming Chiao Tung University 40
Not applicableStudy completedNCT01871116
What this trial is testing

POWER-remote Weight Loss Program in Early Stage Breast Cancer

Who this might be right for
Early Stage Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 96
Not applicableStudy completedNCT00002563
What this trial is testing

SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease

Who this might be right for
LymphomaPsychosocial Effects of Cancer and Its Treatment
SWOG Cancer Research Network 263
Large-scale testing (Phase 3)Study completedNCT01108016
What this trial is testing

Expanding Rural Access: Distance Delivery of Support Groups (Main Study)

Who this might be right for
DepressionBreast CancerStress+3 more
Stanford University 100
Not applicableActive Not RecruitingNCT01644669
What this trial is testing

Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®

Who this might be right for
Invasive Ductal CarcinomaDuctal Carcinoma in Situ
Xoft, Inc. 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT07091305
What this trial is testing

QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)ChemoradiotherapyInduction Therapy+1 more
Shanghai Chest Hospital 28
Early research (Phase 1)Ended earlyNCT03066154
What this trial is testing

Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Netherlands Cancer Institute 24
Not applicableUnknownNCT04079270
What this trial is testing

The Breast Cancer Personalized Nutrition Study

Who this might be right for
Breast Cancer
Sheba Medical Center 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07200154
What this trial is testing

Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC

Who this might be right for
Limited-stage Small-cell Lung CancerConcurrent Chemoradiation Therapy
Peking University Cancer Hospital & Institute 30
Testing effectiveness (Phase 2)UnknownNCT04026841
What this trial is testing

The Efficacy of PD-1 Antibody Sintilimab on Early-stage Multiple Primary Lung Cancer With Ground Glass Density.

Who this might be right for
Multiple Primary Lung Cancers
The First Affiliated Hospital of Guangzhou Medical University 36
Testing effectiveness (Phase 2)Looking for participantsNCT06444269
What this trial is testing

Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center 53
Not applicableStudy completedNCT05588102
What this trial is testing

Electronic Training of Elderly Depression With Cognitive Impairment

Who this might be right for
Geriatric DepressionCognitive Impairment
Capital Medical University 128
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06371807
What this trial is testing

Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab

Who this might be right for
Early Breast CancerTriple Negative Breast Cancer
Fundacao Champalimaud 20
Next Page